Imaging in MGUS, SMM and MM
NCT01237054
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
NIH
Sponsor class
Conditions
Multiple Myeloma
Smoldering Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Interventions
DRUG:
18-NaF PET
OTHER:
DCE-MRI
DRUG:
18-FDG PET/CT
Sponsor
National Cancer Institute (NCI)